Discover how SETBP1 mutations disrupt protein degradation in atypical chronic myeloid leukemia, driving cancer progression through impaired ubiquitination.
Discover how the MYC gene blocks leukemia treatment and prevents cancer cell differentiation, revealing new therapeutic approaches for CML.
Exploring the synergistic combination of FLT3 inhibitors and BH3 mimetics in treating FLT3-ITD Acute Myeloid Leukemia